Meeting
2022 ASCO Genitourinary Cancers Symposium
Evaluating the discriminatory capacity of miR-371A-3P in the context of pure seminomatous testicular cancer metastases.
Authors
Bendu Konneh
University of Texas Southwestern Medical Center, Dallas, TX
Bendu Konneh , John T. Lafin , Anna Savelyeva , Solomon L. Woldu , Cheryl Lewis , Vitaly Margulis , Liwei Jia , Lindsay Lindsay Frazier , Nicholas Coleman , Matthew Murray , Armon Amini , James F. Amatruda , Jeffrey Howard , Cinzia Scarpini , Aditya Bagrodia
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral, and Testicular Cancers
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 40, 2022 (suppl 6; abstr 424)
DOI
10.1200/JCO.2022.40.6_suppl.424
Abstract #
424
Poster Bd #
K9
Abstract Disclosures
Similar Posters
Poster
2019 Genitourinary Cancers Symposium
Predicting vital retroperitoneal residual tumors of metastatic testicular tumor patients after chemotherapy using radiomics.
First Author: Tim Nestler
First Author: Suliman Boulos
Poster
2015 Genitourinary Cancers Symposium
Association of age 40 and older with adverse outcome in metastatic testicular cancer (TC).
First Author: Rowan Miller
Poster
2013 Genitourinary Cancers Symposium
Postchemotherapy retroperitoneal lymph node dissection for advanced germ cell tumors at a Japanese single high-volume center.
First Author: Terukazu Nakamura